Logo image of WRN

WESTERN COPPER AND GOLD CORP (WRN) Stock Fundamental Analysis

NYSEARCA:WRN - NYSE Arca - CA95805V1085 - Common Stock - Currency: USD

1.14  -0.02 (-1.72%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to WRN. WRN was compared to 154 industry peers in the Metals & Mining industry. While WRN seems to be doing ok healthwise, there are quite some concerns on its profitability. WRN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year WRN has reported negative net income.
WRN had a negative operating cash flow in the past year.
In the past 5 years WRN always reported negative net income.
WRN had a negative operating cash flow in each of the past 5 years.
WRN Yearly Net Income VS EBIT VS OCF VS FCFWRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

WRN has a Return On Assets (-3.59%) which is comparable to the rest of the industry.
WRN has a Return On Equity (-3.65%) which is in line with its industry peers.
Industry RankSector Rank
ROA -3.59%
ROE -3.65%
ROIC N/A
ROA(3y)-3.42%
ROA(5y)-3.18%
ROE(3y)-3.53%
ROE(5y)-3.27%
ROIC(3y)N/A
ROIC(5y)N/A
WRN Yearly ROA, ROE, ROICWRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2 -4 -6

1.3 Margins

WRN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WRN Yearly Profit, Operating, Gross MarginsWRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

6

2. Health

2.1 Basic Checks

WRN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for WRN has been increased compared to 5 years ago.
The debt/assets ratio for WRN has been reduced compared to a year ago.
WRN Yearly Shares OutstandingWRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
WRN Yearly Total Debt VS Total AssetsWRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 59.73 indicates that WRN is not in any danger for bankruptcy at the moment.
The Altman-Z score of WRN (59.73) is better than 95.45% of its industry peers.
WRN has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
WRN has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. WRN outperforms 86.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 59.73
ROIC/WACCN/A
WACCN/A
WRN Yearly LT Debt VS Equity VS FCFWRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 22.18 indicates that WRN has no problem at all paying its short term obligations.
WRN has a better Current ratio (22.18) than 95.45% of its industry peers.
WRN has a Quick Ratio of 22.18. This indicates that WRN is financially healthy and has no problem in meeting its short term obligations.
WRN has a Quick ratio of 22.18. This is amongst the best in the industry. WRN outperforms 95.45% of its industry peers.
Industry RankSector Rank
Current Ratio 22.18
Quick Ratio 22.18
WRN Yearly Current Assets VS Current LiabilitesWRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

0

3. Growth

3.1 Past

The earnings per share for WRN have decreased strongly by -53.33% in the last year.
EPS 1Y (TTM)-53.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

WRN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.33% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y78.04%
EPS Next 2Y29.25%
EPS Next 3Y3.06%
EPS Next 5Y6.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WRN Yearly Revenue VS EstimatesWRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 1B 2B 3B
WRN Yearly EPS VS EstimatesWRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6 0.8 1

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WRN. In the last year negative earnings were reported.
Also next year WRN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WRN Price Earnings VS Forward Price EarningsWRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WRN Per share dataWRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.25%
EPS Next 3Y3.06%

0

5. Dividend

5.1 Amount

No dividends for WRN!.
Industry RankSector Rank
Dividend Yield N/A

WESTERN COPPER AND GOLD CORP

NYSEARCA:WRN (5/12/2025, 10:05:29 AM)

1.14

-0.02 (-1.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-06 2025-08-06
Inst Owners25.82%
Inst Owner Change2.15%
Ins Owners4.17%
Ins Owner ChangeN/A
Market Cap226.16M
Analysts80
Price Target2.81 (146.49%)
Short Float %1%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)60.4%
Min EPS beat(2)20.79%
Max EPS beat(2)100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.78%
PT rev (3m)8.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.66
P/tB 1.66
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.69
TBVpS0.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.59%
ROE -3.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.42%
ROA(5y)-3.18%
ROE(3y)-3.53%
ROE(5y)-3.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8766.52%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 22.18
Quick Ratio 22.18
Altman-Z 59.73
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)10232.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.42%
EPS Next Y78.04%
EPS Next 2Y29.25%
EPS Next 3Y3.06%
EPS Next 5Y6.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-87.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.03%
EBIT Next 3Y2.74%
EBIT Next 5YN/A
FCF growth 1Y17.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.53%
OCF growth 3YN/A
OCF growth 5YN/A